Sputum Cytology in Screening Heavy Smokers For Lung Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00103363|
Recruitment Status : Completed
First Posted : February 8, 2005
Last Update Posted : May 7, 2014
RATIONALE: Screening tests, such as sputum cytology, may help doctors find tumor cells early and plan better treatment for lung cancer.
PURPOSE: This phase II trial is studying how well sputum cytology works in screening heavy smokers for lung cancer.
|Condition or disease||Intervention/treatment||Phase|
|Lung Cancer||Other: cytology specimen collection procedure Other: physiologic testing Procedure: annual screening Procedure: study of high risk factors||Phase 2|
- Classify annual sputum samples cytologically in participants with or without airflow obstruction and a heavy smoking history.
- Correlate sputum cytological atypia (moderate atypia or worse) with lung cancer incidence in these participants.
- Correlate changes in sputum cytology (i.e., changes toward higher grades of atypia) with lung cancer incidence in these participants.
- Determine other risk factors for lung cancer (e.g., diet, family history, smoking history, and medications) that may either confound or modify the association between sputum cytology and lung cancer risk in these participants.
OUTLINE: Two 3-day pooled sputum samples are collected for 6 consecutive days from participants by the spontaneous cough technique for cytopathological evaluation. Participants also complete a risk factor questionnaire and undergo a pulmonary function test by spirometry and a blood draw.
Participants complete a questionnaire updating smoking, vital, and lung cancer status and undergo sputum sample collection annually.
Participants are informed of sputum cytology results.
PROJECTED ACCRUAL: A total of 3,400 participants (2,900 with airflow obstruction and 500 without airflow obstruction) will be accrued for this study.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||3270 participants|
|Official Title:||Lung Cancer Screening and Tissue Procurement|
|Study Start Date :||February 1993|
|Actual Primary Completion Date :||February 1994|
|Actual Study Completion Date :||February 1994|
- Classification of annual sputum samples cytologically
- Correlation of sputum cytological atypia (moderate atypia or worse) with lung cancer incidence
- Correlation of changes in sputum cytology with lung cancer incidence
- Risk factors for lung cancer that may effect the association between sputum cytology and lung cancer risk
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00103363
|United States, Colorado|
|University of Colorado Health Sciences Center - Denver|
|Denver, Colorado, United States, 80262|
|Principal Investigator:||Timothy Kennedy||University of Colorado, Denver|